Is Tesla (TSLA) Putting the AI Cart Before the EV Horse?
A long term Tesla shareholder thinks the EV company is not focused and has low hopes for its AI dreams.
BTC$59,815.00+0.91%
ETH$1,558.83-0.24%
USDT$0.9985+0.02%
USDC$0.99970.00%
XRP$1.04+1.36%
SOL$70.37+8.55%
TRX$0.3195-1.11%
FIGR_HELOC$1.03+0.59%
HYPE$63.84+6.54%
DOGE$0.0743+1.66%
RAIN$0.0157-0.39%
USDS$0.99950.00%
LEO$9.28-0.56%
ZEC$406.04+2.85%
XLM$0.1747-0.99%
BTC$59,815.00+0.91%
ETH$1,558.83-0.24%
USDT$0.9985+0.02%
USDC$0.99970.00%
XRP$1.04+1.36%
SOL$70.37+8.55%
TRX$0.3195-1.11%
FIGR_HELOC$1.03+0.59%
HYPE$63.84+6.54%
DOGE$0.0743+1.66%
RAIN$0.0157-0.39%
USDS$0.99950.00%
LEO$9.28-0.56%
ZEC$406.04+2.85%
XLM$0.1747-0.99%
J.M. Smucker and Super Micro Computer face significant challenges. Meanwhile, Warren Buffett's Berkshire Hathaway achieves a historic milestone.
A long term Tesla shareholder thinks the EV company is not focused and has low hopes for its AI dreams.
Insulet Corporation surged on FDA approval for its diabetes treatment device, while SMCI faced pressure from a short-seller report, and Paycom Software saw insider selling activity.
Uber Technologies Inc. faces a $324 million fine from EU regulators.
Canada has announced a 100% surtax on China-made electric vehicles, effective October 1, 2024, impacting Tesla and other automakers.
Nvidia became the equity hedge akin to Bitcoin against currency devaluation. Will this track record continue?
Tech and auto giants Tesla, GM, and Nvidia are making waves in the stock market with significant developments and price movements.
Federal Reserve Chair Jerome Powell signaled a major shift towards cutting interest rates during his speech at the Jackson Hole Economic Symposium.
Tesla faces challenges in Europe, while Charles Schwab sees a major shareholder reducing its stake. Meanwhile, Paramount Global's stock shows signs of life.
Short squeeze opportunities are tough to find. Combine market timing with fundamentals for these stocks.
Merck's wider drug moat and acquisition spree makes it a safer bet but VKTX can be the next LLY.
Eli Lilly's stock surged on news of its diabetes drug while Tesla saw a modest gain following news of reduced EU tariffs. Meanwhile, BAC declined after…
Mpox rerun is making these stocks soar. But a non-vaccine approach could yield greater gains.